Title : Lipodystrophy in patients with acromegaly receiving pegvisomant.

Pub. Date : 2008 Sep

PMID : 18611977






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONTEXT: Pegvisomant, a GH receptor antagonist, suppresses serum IGF-I levels into the normal range in more than 95% of patients with acromegaly. pegvisomant insulin like growth factor 1 Homo sapiens
2 Pegvisomant suppressed IGF-I levels into the normal range in five of seven subjects, before discontinuation of the drug. pegvisomant insulin like growth factor 1 Homo sapiens